In a significant legislative move, the North Carolina Senate has advanced a stringent medical marijuana bill to the House, seeking final approval as the 2024 session nears its end. This marks the third consecutive year the Senate has passed such a bill, each time with bipartisan support. However, previous efforts have stalled in the House.
READ MORE
A groundbreaking clinical trial in Australia is exploring the potential of a new CBD-based capsule to combat insomnia. Conducted by Melbourne biotech company Avecho, the trial seeks to recruit 519 participants suffering from episodic insomnia—sleep disturbances lasting one to three months. The capsule, taken once daily before bed, contains cannabidiol (CBD), a compound known for
READ MORE
In 2021, Alabama took a significant step by approving a medical marijuana program, promising relief for patients with qualifying conditions. However, three years later, patients are still waiting for access to cannabis products. The delays have been attributed to bureaucratic hurdles and regulatory challenges that have slowed the program’s implementation. Despite the initial optimism, the
READ MORE
In a decisive move to safeguard public health, Missouri has announced a ban on the sale of Delta-8 THC and other hemp-derived intoxicants, effective September 1. This prohibition targets products such as drinks, candy, and other edibles infused with these substances, which have surged in popularity but remain largely unregulated. State officials expressed concerns over
READ MORE
In a significant development for medical marijuana advocates in Arkansas, state officials have granted an additional 30 days for the collection of signatures to support a ballot initiative aimed at expanding the state’s medical cannabis program. The campaign, led by Arkansans for Patient Access (APA), initially submitted nearly 110,000 signatures but fell short of the
READ MORE
Cannabidiol (CBD), a non-psychoactive compound found in cannabis, is gaining attention for its potential to alleviate symptoms of ulcerative colitis (UC), a chronic inflammatory bowel disease. Some studies suggest CBD may help reduce inflammation and improve quality of life for UC patients, though the evidence remains inconclusive. Keith Sharkey, Ph.D., from the University of Calgary,
READ MORE
